BusinessWire India
Ahmedabad (Gujarat) [India], May 20: Zydus Lifesciences Limited introduced monetary outcomes for the quarter / 12 months ended on March 31, 2025.
Key Financial Highlights
FY25
– Revenue from operations up by 19% at Rs. 2,32,415 mn, over final 12 months.
– Net Profit, adjusted for distinctive gadgets, was Rs. 47,451 mn, up 23% YoY.
– EBITDA for the 12 months was Rs. 70,585 mn, up 31% YoY. EBITDA margin for the 12 months stood at 30.4%, which is an enchancment of 290 bps over the earlier 12 months.
– Net Debt to Equity ratio as on thirty first March, 2025 was -0.20x whereas Net Debt to EBITDA stood at -0.69x on the finish of March, 2025. Net Cash (destructive Net Debt) as on March thirty first, 2025 was Rs. 48,836 mn .
-Research & Development (R&D) investments for the 12 months stood at Rs. 18,555 mn (8.0% of revenues).
-The Board beneficial a dividend of 1100%.
This autumn FY25
– Revenue from operations up by 18% at Rs. 65,279 mn, over final 12 months.
– EBITDA for the quarter was Rs. 21,255 mn, up 30% YoY. EBITDA margin for the quarter stood at 32.6%, which is an enchancment of 310 bps on a YoY foundation.
-Net Profit up 18% yoy at Rs. 13,905 mn (adjusted for distinctive gadgets).
-Research & Development (R&D) investments for the quarter stood at Rs. 4,799 mn (7.4% of revenues).
Speaking on the outcomes, Dr. Sharvil Patel, Managing Director Zydus Lifesciences stated, “We are completely satisfied to conclude FY 2025 on a robust word, with all our companies surpassing our development expectations. The business success of our intensive product portfolio mixed with working leverage has considerably bolstered profitability and monetary well being. We made significant progress in our differentiated pipeline and added new capabilities to make sure sustainable development. We sit up for continued execution success and deepening strategic partnerships to drive long run development. Our dedication to sustaining the very best high quality requirements throughout our operations stays unwavering.”
(ADVERTORIAL DISCLAIMER: The above press launch has been offered by BusinessWire India. ANI is not going to be accountable in any approach for the content material of the identical)
(The story has come from a syndicated feed and has not been edited by OXBIG NEWS NETWORK Staff.)
#Zydus #Net #Profit #Tribune
Advertorial Disclaimer,BusinessWire India,Development,EBITDA,monetary outcomes,Zydus
newest information in the present day, information in the present day, breaking information, newest information in the present day, english information, web information, high information, oxbig, oxbig information, oxbig information community, oxbig information in the present day, information by oxbig, oxbig media, oxbig community, oxbig information media
HINDI NEWS
News Source
